TPU Research Areas
► Reactor and cyclotron radiopharmaceutical agents for early detection and treatment of oncological, cardiovascular, neurological, endocrine and inflammatory diseases as well as joint disorders;
► Neutron capture cancer treatment;
► Methods of radionuclide theranostics personalising and planning;
► Contrast agents for positron-emission, magnetic-resonance, ultrasonic and X-ray methods of diagnostics;
► Natural-compound precursors for radiopharmaceutical agents;
► Radioactive isotope synthesis technologies for biomedical research.
Calgary University (Canada); Albany Medical College (USA); Tomsk Cancer Research Institute SB RAMS; Cardiology Research Institute SB RAMS; Siberian State Medical University; Open University Skolkovo; Humboldt-Universität zu Berlin (Germany); Far Eastern Federal University; Novosibirsk Institute of Organic Chemistry SB RAMS; “Isotope” OJSC; Join Stock Company “D.V.Efremov Institute of Electrophysical Apparatus”, “PHARM-SINTEZ” CJSC; Federal V.A. Almazov Medical Research Centre of the Ministry of Health of the Russian Federation; Medical University Graz (Austria); Institute of Physiology Academy of Sciences of the Czech Republic (Czech Republic); University Hospital of Würzburg Clinic of Nuclear Medicine (Germany).
Cluster Academic Curriculum
Master Degree program “Biomedical Engineering”:
► Nuclear and biologically friendly materials engineering
► Medical physics